ONA THERAPEUTICS
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
ONA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.ona-therapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
31.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin Google Maps
Current Advisors List
Current Employees Featured
Founder
Investors List
Fund+
Fund+ investment in Series A - Ona Therapeutics
Bpifrance
Bpifrance investment in Series A - Ona Therapeutics
Asabys Partners
Asabys Partners investment in Series A - Ona Therapeutics
Ysios Capital
Ysios Capital investment in Series A - Ona Therapeutics
Alta Life Sciences
Alta Life Sciences investment in Series A - Ona Therapeutics
Asabys Partners
Asabys Partners investment in Seed Round - Ona Therapeutics
Official Site Inspections
http://www.ona-therapeutics.com
- Host name: box5466.bluehost.com
- IP address: 162.241.217.75
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Ona Therapeutics"
Ona Therapeutics - Crunchbase Company Profile & Funding
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded …See details»
ONA Therapeutics - LinkedIn
ONA Therapeutics Biotechnology Research Barcelona, Catalonia 6,636 followers First-in-class ADCs tailor designed to attack advanced cancerSee details»
Ona Therapeutics Company Profile - Office Locations ... - Craft
Ona Therapeutics is a biotechnology company intended to discover and develop therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Its therapeutic …See details»
Ona Therapeutics - Contacts, Employees, Board Members
Organization. Ona Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
Ona Therapeutics raised €30M in Series A financing
Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announced in June 2020 the closing of a €30 million Series A …See details»
Ona Therapeutics - Funding, Financials, Valuation & Investors
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Home - Ona Therapeutics
We develop novel therapies against metastatic cancer 01 about US. Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic …See details»
Ona’s €30m Series A round: directly targeting metastasis in cancer
Jul 2, 2020 Ysios’s Jean-Mairet added: “Over the past years, we have evaluated around 600 companies active in oncology and Ona Therapeutics stands out for its singularity and potential …See details»
ONA Therapeutics Strengthens Scientific Leadership Team - PR …
BARCELONA, Spain, Oct. 21, 2021 /PRNewswire/ -- ONA Therapeutics ("ONA"), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism …See details»
Ona Therapeutics - IRB Barcelona
Ona Therapeutics was launched in 2019 and is specialised in the discovery and development of therapeutic biologics targeting tumour metastasis-initiating cells and lipid metabolism. This …See details»
Ona Therapeutics - PitchBook
When was Ona Therapeutics founded? Ona Therapeutics was founded in 2019. Where is Ona Therapeutics headquartered? Ona Therapeutics is headquartered in Barcelona, Spain. What …See details»
Ona Therapeutics, one of 2020’s Fierce 15 biotechnology …
Sep 29, 2020 Ona Therapeutics, the biotech company created by IRB Barcelona and ICREA that focuses on the development of a new drug for the treatment of metastatic cancer, has …See details»
A fat-blocking drug could help to fight metastatic cancer - Nature
May 24, 2023 Research at ONA Therapeutics has focused on detailing how the company's system works at a molecular level. Credit: ONA Therapeutics. ONA Therapeutics in Barcelona, …See details»
A drug to block fat intake and combat cancer spread - Nature
Jun 24, 2021 Salvador Aznar Benitah’s research led to the creation of ONA Therapeutics. Credit: IRB Barcelona. ONA Therapeutics is a spin-off from the Institute for Research in Biomedicine, …See details»
ONA Therapeutics Strengthens Scientific Leadership Team
Oct 21, 2021 ONA THERAPEUTICS, SL, declares to have implemented the necessary technical and organizational security measures that guarantee the security of the data and prevent its …See details»
Ona Therapeutics raises €30M in Series A financing
Jun 16, 2020 Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million …See details»
Ona Therapeutics | Ona Therapeutics is named as one of Fierce …
Sep 28, 2020 ONA THERAPEUTICS, SL, declares to have implemented the necessary technical and organizational security measures that guarantee the security of the data and …See details»
Valerie Vanhooren, PhD - Ona Therapeutics
ONA THERAPEUTICS, SL, declares to have implemented the necessary technical and organizational security measures that guarantee the security of the data and prevent its …See details»
Ona raises €30M to treat metastases by blocking fat intake
Jun 16, 2020 Ona Therapeutics has raised a €30 million ($34 million) series A round to take biologics that treat metastatic cancer into clinical trials. The R&D plan is underpinned by early …See details»